In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Protometrix Inc.

Division of Thermo Fisher Scientific Inc.
www.protometrix.com

Latest From Protometrix Inc.

Start-Up Previews (07/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups feature companies involved in Congestive Heart Failure Devices, Pain Therapeutics, and Protein-Based Drug Discovery. Plus these selected Start-Ups across Health Care: Enanta Pharmaceuticals Inc., etrials Inc. and Organ Recovery Systems Inc.

Protometrix Inc.

Protometrix's microarray technology enables it to produce, purify, and assay thousands of proteins at once on a solid surface. With this skill set, the company believes it can become the first firm able to offer drug developers the ability to scan the entire human proteome in a high-throughput setting.
BioPharmaceutical Research and Development Strategies

Downward Trends in Proteomics Deal Making

For more than a year, VCs have backed away from the proteomics tools group--drug companies hadn't signed the expected number and value of deals with them, and it was deal revenues that were, according to most business plans, going to support these start-ups. That pharma and biotech companies have a bigger appetite for products than for platform technology has become a truism. Licensors increasingly are finding that they must offer partners more than a discovery technology platform-either by validating targets and building value before out-licensing, or at least having the biological capability in-house to be a true collaborator.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Thermo Fisher Scientific Inc.
  • Senior Management
  • Hollis D Kleinert, Pres. & CEO
    Paul F Predki, VP, R&D
  • Contact Info
  • Protometrix Inc.
    Phone: (203) 458-5868
    66 High St.
    Guilford, CT 06437
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register